EHC/LinkedIn
Apr 7, 2026, 16:44
A Call to Get the Biotech Act Right for The Millions Living with Bleeding Disorders – EHC
EHC – European Haemophilia Consortium shared on LinkedIn:
”Innovation without access is not progress.
On World Health Day, the EHC is calling on EU policymakers to get the Biotech Act right for the millions living with bleeding disorders who cannot afford to wait.
Science is moving fast.
Regulation and access must keep up.
The EHC demands:
- Patients at the table, not as an afterthought, but at every stage of research, trials, and regulatory decisions
- Real-world evidence that counts, because clinical trial data alone do not capture the full picture of patients’ lives
- Cross-border clinical trials to break down barriers and bring innovation to patients across Europe, no matter where they live
The theme of World Health Day 2026 is ‘Together for health: stand with science’.
Standing with science means ensuring that science stands for patients.
The EU Biotech Act is an opportunity. Let’s not waste it.
Stay updated with Hemostasis Today.
-
Jul 10, 2026, 10:58Yara Alyahyawi: Advancing Epigenetic Therapy for Hemophilia B
-
Jul 10, 2026, 10:23Stephen Brown: Help Us Shape The Future of Hemophilia A Care
-
Jul 10, 2026, 09:57Katherine Rozycki: The Future of Haematology Through Education
-
Jul 10, 2026, 09:42Biljana Andrić: The Best Transfusion Is Often The One That Can Be Avoided
-
Jul 10, 2026, 09:27Farnaz Poorhasan: FFP is More Than Just Frozen Blood Components
-
Jul 10, 2026, 02:32Nina Laue: Looking Forward to Connecting and Collaborating at ISTH 2026
-
Jul 10, 2026, 02:19Anita Singla: Thalassemia Screening in Pregnancy Has a Lifelong Impact
-
Jul 10, 2026, 02:07Ruman Bashir: Immune Thrombocytopenia in Pregnancy
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation